Verisante Technology Inc. (VRSEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
+0.0070 (233.33%)
Apr 23, 2025, 4:00 PM EDT
Verisante Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
439.38K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Verisante Technology News
- 24 days ago - Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG - Accesswire
- 4 months ago - Verisante Technology, Inc. Announces RTO Update: - Accesswire
- 6 months ago - Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG - Accesswire
- 9 months ago - Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Shares for Debt Agreements - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces 2023 AGM Results - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction - Accesswire